Bernhard Ellinger
Department Screening Port
Hamburg, HH 22525, Germany
Hamburg, HH 22525, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
APOL1 plasma membrane pools resist rapid protein degradation.
Journal: Scientific reports
Published: November 17, 2025
Design of 2-Aminobenzothiazole Derivatives Targeting Trypanosomatid PTR1 by a Multidisciplinary Fragment Hybridization Approach.
Journal: Journal of medicinal chemistry
Published: September 30, 2025
Activating PRKG1 Variant Enhances Smooth Muscle Cell Deformability to Cause Aortopathy.
Journal: JACC. Basic to translational science
Published: August 23, 2025
Retinoic acid-induced 2 deficiency impairs genomic stability in breast cancer.
Journal: Breast cancer research : BCR
Published: January 16, 2025
High-Throughput Phenotypic Screening and Machine Learning Methods Enabled the Selection of Broad-Spectrum Low-Toxicity Antitrypanosomatidic Agents.
Journal: Journal of medicinal chemistry
Published: November 03, 2023
Discovery of 5-Phenylpyrazolopyrimidinone Analogs as Potent Antitrypanosomal Agents with In Vivo Efficacy.
Journal: Journal of medicinal chemistry
Published: July 20, 2023
Design, synthesis and biological evaluation of antiparasitic dinitroaniline-ether phospholipid hybrids.
Journal: Bioorganic chemistry
Published: March 25, 2023
Discovery of 1-Benzhydryl-Piperazine-Based HDAC Inhibitors with Anti-Breast Cancer Activity: Synthesis, Molecular Modeling, In Vitro and In Vivo Biological Evaluation.
Journal: Pharmaceutics
Published: November 01, 2022
Multitarget, Selective Compound Design Yields Potent Inhibitors of a Kinetoplastid Pteridine Reductase 1.
Journal: Journal of medicinal chemistry
Published: June 08, 2022
High-throughput drug screening allowed identification of entry inhibitors specifically targeting different routes of SARS-CoV-2 Delta and Omicron/BA.1.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 29, 2022
Application of the Adverse Outcome Pathway Concept to In Vitro Nephrotoxicity Assessment: Kidney Injury due to Receptor-Mediated Endocytosis and Lysosomal Overload as a Case Study.
Journal: Frontiers in toxicology
Published: January 28, 2022
Last Updated: 09/26/2026